Baillie Gifford European Growth Ord (BGEU.L)
| Previous close | 95.10 |
| Open | 95.30 |
| Bid | 95.90 x N/A |
| Ask | 96.70 x N/A |
| Day's range | 94.63 - 96.10 |
| 52-week range | 75.38 - 111.47 |
| Volume | |
| Avg. volume | 618,751 |
| Market cap | 341.462M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 12.01 |
| EPS (TTM) | N/A |
| Earnings date | 10 May 2024 - 14 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GuruFocus.comBaillie Gifford's Strategic Moves in Q1 2024: A Closer Look at NVIDIA Corp's Adjustment
Insight into Baillie Gifford (Trades, Portfolio)'s Latest 13F Filing and Its Impact on Key Holdings
GuruFocus.comBaillie Gifford Bolsters Stake in Mobileye Global Inc
On March 1, 2024, Baillie Gifford (Trades, Portfolio), a renowned investment management firm, made a notable addition to its investment portfolio by acquiring 7,560,929 shares of Mobileye Global Inc (NASDAQ:MBLY), a leader in autonomous driving technologies. This transaction increased Baillie Gifford (Trades, Portfolio)'s total holdings in the company to 15,985,212 shares, reflecting a significant trade impact of 0.16% on its portfolio.
GuruFocus.comBaillie Gifford Bolsters Stake in Sana Biotechnology Inc
Baillie Gifford (Trades, Portfolio), the renowned investment management firm, has recently expanded its investment portfolio by adding a significant number of shares in Sana Biotechnology Inc (NASDAQ:SANA). This move underscores the firm's confidence in the biotechnology company's growth potential. On February 1, 2024, Baillie Gifford (Trades, Portfolio) acquired an additional 210,603 shares of Sana Biotechnology, reflecting a 2.07% change in their holdings and bringing the total shares owned to 10,360,620.
